Larimar Therapeutics, Inc.盘中异动临近午盘股价大跌5.05%

自选股智能写手07-18

北京时间2024年07月18日23时44分，Larimar Therapeutics, Inc.（LRMR.us）股票出现异动，股价大幅下挫5.05%。截至发稿，该股报9.58美元/股，成交量7.6139万股，换手率0.12%，振幅6.24%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-14.65百万美元，每股收益-0.27美元，毛利-80000.00美元，市盈率-10.02倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2452361324?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-18 23:44","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2452361324","market":"us","top_or_hot":-1,"title":"Larimar Therapeutics, Inc.盘中异动 临近午盘股价大跌5.05%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年07月18日23时44分，Larimar Therapeutics, Inc.（LRMR.us）股票出现异动，股价大幅下挫5.05%。截至发稿，该股报9.58美元/股，成交量7.6139万股，换手率0.12%，振幅6.24%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-14.65百万美元，每股收益-0.27美元，毛利-80000.00美元，市盈率-10.02倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718234402af930065&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Larimar Therapeutics, Inc.盘中异动 临近午盘股价大跌5.05%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLarimar Therapeutics, Inc.盘中异动 临近午盘股价大跌5.05%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-18 23:44 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718234402af930065&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年07月18日23时44分，Larimar Therapeutics, Inc.（LRMR.us）股票出现异动，股价大幅下挫5.05%。截至发稿，该股报9.58美元/股，成交量7.6139万股，换手率0.12%，振幅6.24%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-14.65百万美元，每股收益-0.27美元，毛利-80000.00美元，市盈率-10.02倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718234402af930065&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718234402af930065&s=b","article_id":"2452361324","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718234402af930065&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2452361324","pubTimestamp":1721317441,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年07月18日23时44分，Larimar Therapeutics, Inc.股票出现异动，股价大幅下挫5.05%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.88%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。消息层面，截至23时44分，《LifeSci Capital维持Larimar Therapeutics买入评级，维持目标价36美元》资讯为影响Larimar Therapeutics, Inc.的重要信息。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","BK4139":"生物科技","LRMR":"Larimar Therapeutics, Inc."},"translate_title":"Larimar Therapeutics, Inc. 's intraday movement plunged 5.05% near midday","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"LRMR":1},"content_text":"北京时间2024年07月18日23时44分，Larimar Therapeutics, Inc.（LRMR.us）股票出现异动，股价大幅下挫5.05%。截至发稿，该股报9.58美元/股，成交量7.6139万股，换手率0.12%，振幅6.24%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-14.65百万美元，每股收益-0.27美元，毛利-80000.00美元，市盈率-10.02倍。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.88%。其相关个股中，Onconetix, Inc.、Silo Pharma, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)涨幅较大，Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为2213.37%、1934.96%、1169.07%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。该公司的主要候选产品CTI-1601是一种皮下给药的重组融合蛋白，旨在传递一种人体共济失调患者线粒体中的必需蛋白，即frataxin (FXN)。消息层面，截至23时44分，《LifeSci Capital维持Larimar Therapeutics(LRMR.US)买入评级，维持目标价36美元》资讯为影响Larimar Therapeutics, Inc.的重要信息。该信息摘要如下：LifeSci Capital分析师Cory Jubinville, PhD维持Larimar Therapeutics 买入评级，维持目标价36美元。根据TipRanks数据显示，该分析师近一年总胜率为57.6%，总平均回报率为35.5%。总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2452361324"}

Larimar Therapeutics, Inc.盘中异动 临近午盘股价大跌5.05%

精彩评论

Larimar Therapeutics, Inc.盘中异动临近午盘股价大跌5.05%